| Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications SM Meeran, SN Patel, Y Li, S Shukla, TO Tollefsbol PloS one 7 (5), e37748, 2012 | 129 | 2012 |
| Centchroman altered the expressions of tumor‐related genes through active chromatin modifications in mammary cancer S Khan, S Shukla, S Sinha, SM Meeran Molecular Carcinogenesis 55 (11), 1747-1760, 2016 | 9 | 2016 |
| Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis S Khan, S Shukla, M Farhan, S Sinha, AD Lakra, D Penta, A Kannan, ... Life Sciences 256, 117976, 2020 | 23 | 2020 |
| Centchroman suppresses breast cancer metastasis by reversing epithelial–mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling S Khan, S Shukla, S Sinha, AD Lakra, HK Bora, SM Meeran The International Journal of Biochemistry & Cell Biology 58, 1-16, 2015 | 60 | 2015 |
| Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 J Donovan, Z Deng, F Bian, S Shukla, J Gomez-Arroyo, D Shi, ... Frontiers in Oncology 13, 1163510, 2023 | | 2023 |
| Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis S Shukla, S Khan, S Kumar, S Sinha, M Farhan, HK Bora, R Maurya, ... Cancer prevention research 8 (6), 552-562, 2015 | 58 | 2015 |
| Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis S Sinha, S Khan, S Shukla, AD Lakra, S Kumar, G Das, R Maurya, ... The international journal of biochemistry & cell biology 77, 41-56, 2016 | 66 | 2016 |
| Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis S Shukla, S Sinha, S Khan, S Kumar, K Singh, K Mitra, R Maurya, ... Scientific reports 6 (1), 21860, 2016 | 73 | 2016 |
| Demonstration of safety in wild type mice of npFOXF1, a novel nanoparticle-based gene therapy for alveolar capillary dysplasia with misaligned pulmonary veins F Kohram, Z Deng, Y Zhang, A Al Reza, E Li, OA Kolesnichenko, S Shukla, ... Biologics: Targets and Therapy, 43-55, 2023 | 2 | 2023 |
| Epigenetic factors in breast cancer progression S Shukla, SM Meeran Breast Cancer Metastasis and Drug Resistance: Progress and Prospects, 341-365, 2013 | 6 | 2013 |
| Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells S Sinha, S Shukla, S Khan, TO Tollefsbol, SM Meeran Molecular and cellular endocrinology 406, 102-114, 2015 | 51 | 2015 |
| Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention S Shukla, SM Meeran, SK Katiyar Cancer letters 355 (1), 9-17, 2014 | 149 | 2014 |
| Epigenetic targets in cancer and aging: dietary and therapeutic interventions S Khan, S Shukla, S Sinha, SM Meeran Expert opinion on therapeutic targets 20 (6), 689-703, 2016 | 30 | 2016 |
| Epigenetic Tools and Pathogenesis of Lung Cancer S Shukla, M Fathima, SM Meeran SCIENCE AND HUMANITIES, 641, 2015 | | 2015 |
| Epigenetics in Cancer Prevention and Therapy: Role of Phytochemicals S Khan, S Shukla, SM Meeran Rediscovering Cancer: From Mechanism to Therapy, 515-548, 2018 | | 2018 |
| Epigenetics of breast cancer: clinical status of epi-drugs and phytochemicals S Shukla, D Penta, P Mondal, SM Meeran Breast cancer metastasis and drug resistance: challenges and progress, 293-310, 2019 | 60 | 2019 |
| Epigenetics of cancer stem cells: Pathways and therapeutics S Shukla, SM Meeran Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (12), 3494-3502, 2014 | 142 | 2014 |
| FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma D Milewski, S Shukla, BE Gryder, A Pradhan, J Donovan, P Sudha, ... Oncogene 40 (12), 2182-2199, 2021 | 22 | 2021 |
| FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation M Black, P Arumugam, S Shukla, A Pradhan, V Ustiyan, D Milewski, ... Molecular Biology of the Cell 31 (13), 1411-1424, 2020 | 30 | 2020 |
| Genetics and epigenetics of lung cancer: mechanisms and future perspectives S Shukla, S Khan, T O Tollefsbol, S M Meeran Current Cancer Therapy Reviews 9 (2), 97-110, 2013 | 17 | 2013 |
Syed Musthapa MeeranSenior Principal Scientist & Professor, Department of Biochemistry, CSIR-CFTRI在 cftri.res.in 的电子邮件经过验证
